494 related articles for article (PubMed ID: 24382515)
21. MicroRNA-211 expression is down-regulated and associated with poor prognosis in human glioma.
Zhang J; Lv J; Zhang F; Che H; Liao Q; Huang W; Li S; Li Y
J Neurooncol; 2017 Jul; 133(3):553-559. PubMed ID: 28551850
[TBL] [Abstract][Full Text] [Related]
22. Expression and clinical significance of microRNA-326 in human glioma miR-326 expression in glioma.
Wang S; Lu S; Geng S; Ma S; Liang Z; Jiao B
Med Oncol; 2013 Mar; 30(1):373. PubMed ID: 23292865
[TBL] [Abstract][Full Text] [Related]
23. Increased expression of microRNA-17 predicts poor prognosis in human glioma.
Lu S; Wang S; Geng S; Ma S; Liang Z; Jiao B
J Biomed Biotechnol; 2012; 2012():970761. PubMed ID: 23226946
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of coexistence of abnormal expression of micro-RNA-200b and cyclic adenosine monophosphate-responsive element-binding protein 1 in human astrocytoma.
Zhang JQ; Yao QH; Kuang YQ; Ma Y; Yang LB; Huang HD; Cheng JM; Yang T; Liu EY; Liang L; Fan KX; Zhao K; Xia X; Gu JW
Hum Pathol; 2014 Oct; 45(10):2154-61. PubMed ID: 25033730
[TBL] [Abstract][Full Text] [Related]
25. High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma.
Guan Y; Chen L; Bao Y; Qiu B; Pang C; Cui R; Wang Y
Int J Clin Exp Pathol; 2015; 8(6):6576-88. PubMed ID: 26261539
[TBL] [Abstract][Full Text] [Related]
26. Differential expression of microRNA-210 in gliomas of variable cell origin and correlation between increased expression levels and disease progression in astrocytic tumours.
Lai N; Zhu H; Chen Y; Zhang S; Zhao X; Lin Y
Folia Neuropathol; 2014; 52(1):79-85. PubMed ID: 24729345
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of microRNA-224 confers a poor prognosis in glioma patients.
Lu S; Wang S; Geng S; Ma S; Liang Z; Jiao B
Clin Transl Oncol; 2013 Jul; 15(7):569-74. PubMed ID: 23263909
[TBL] [Abstract][Full Text] [Related]
28. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
[TBL] [Abstract][Full Text] [Related]
29. Predictive and Prognostic Roles of Abnormal Expression of Tissue miR-125b, miR-221, and miR-222 in Glioma.
Li X; Zheng J; Chen L; Diao H; Liu Y
Mol Neurobiol; 2016 Jan; 53(1):577-583. PubMed ID: 25502291
[TBL] [Abstract][Full Text] [Related]
30. High CHI3L1 expression is associated with glioma patient survival.
Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
[TBL] [Abstract][Full Text] [Related]
31. Decreased Expression of miR-15b in Human Gliomas is Associated with Poor Prognosis.
Sun G; Yan S; Shi L; Wan Z; Jiang N; Li M; Guo J
Cancer Biother Radiopharm; 2015 May; 30(4):169-73. PubMed ID: 25811315
[TBL] [Abstract][Full Text] [Related]
32. Stratifin expression is a novel prognostic factor in human gliomas.
Deng J; Gao G; Wang L; Wang T; Yu J; Zhao Z
Pathol Res Pract; 2011 Nov; 207(11):674-9. PubMed ID: 21940111
[TBL] [Abstract][Full Text] [Related]
33. The Potential Prognostic Value of MicroRNA-429 for Human Gliomas.
Sun X; Li Z; Chen Y
Ann Clin Lab Sci; 2016; 46(1):44-8. PubMed ID: 26927341
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of chromatin remodeling factor CHD5 is associated with a poor prognosis in human glioma.
Wang L; He S; Tu Y; Ji P; Zong J; Zhang J; Feng F; Zhao J; Gao G; Zhang Y
J Clin Neurosci; 2013 Jul; 20(7):958-63. PubMed ID: 23707602
[TBL] [Abstract][Full Text] [Related]
35. Decreased expression of microRNA-200b is an independent unfavorable prognostic factor for glioma patients.
Men D; Liang Y; Chen L
Cancer Epidemiol; 2014 Apr; 38(2):152-6. PubMed ID: 24559637
[TBL] [Abstract][Full Text] [Related]
36. Expression of CRM1 in human gliomas and its significance in p27 expression and clinical prognosis.
Shen A; Wang Y; Zhao Y; Zou L; Sun L; Cheng C
Neurosurgery; 2009 Jul; 65(1):153-9; discussion 159-60. PubMed ID: 19574837
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of the immunohistochemical staining of cleaved caspase-3, an activated form of caspase-3, in gliomas.
Kobayashi T; Masumoto J; Tada T; Nomiyama T; Hongo K; Nakayama J
Clin Cancer Res; 2007 Jul; 13(13):3868-74. PubMed ID: 17606719
[TBL] [Abstract][Full Text] [Related]
38. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.
Li H; Yu L; Liu J; Bian X; Shi C; Sun C; Zhou X; Wen Y; Hua D; Zhao S; Ren L; An T; Luo W; Wang Q; Yu S
Oncotarget; 2017 Mar; 8(12):19723-19737. PubMed ID: 28160566
[TBL] [Abstract][Full Text] [Related]
39. Expression of high-mobility group AT-hook protein 2 and its prognostic significance in malignant gliomas.
Liu B; Pang B; Hou X; Fan H; Liang N; Zheng S; Feng B; Liu W; Guo H; Xu S; Pang Q
Hum Pathol; 2014 Aug; 45(8):1752-8. PubMed ID: 24935062
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of miR-154 in human glioma and its clinicopathological and prognostic significance.
Wang L; Wu L; Wu J
J Int Med Res; 2016 Oct; 44(5):994-1001. PubMed ID: 27417886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]